Medication-Assisted Treatment Clinical Pathway and Rate Design Tool (PDF - 65.5 KB KB)
Describes service delivery models and corresponding rate design tools for the provision of MAT to individuals with opioid dependence.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Describes service delivery models and corresponding rate design tools for the provision of MAT to individuals with opioid dependence.
Includes profiles for all 50 States that detail the State authority for controlled substances and links to any relevant regulations, rules, and prescription drug monitoring programs.
Addresses NAS, including maternal risk factors during pregnancy, social risk factors, assessment, and treatment.
Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.
Guides clinicians through a series of questions to identify risky substance use in their adult patients. Accompanying resources assist clinicians in providing patient feedback and arranging for specialty care, where necessary, using the 5 As of intervention.
Assesses frequency of use and abuse of substances (e.g., alcohol, tobacco, prescription and illegal drugs, and controlled medications) to determine if an intervention is needed.
Details the material risks associated with the medication and risk of physical dependence.